Bosutinib Monohydrate
In Stock•Starting at $23 for 1 mg•Purity ≥ 98%
| CAS No. | 918639-08-4 |
|---|---|
| MDL No. | MFCD29920031 |
| MF | C26H31Cl2N5O4 |
| MW | 548.50 |
| InChI Key | BXPOSPOKHGNMEP-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | To Be Confirmed | $23 | In Stock | |
| 5 mg | To Be Confirmed | $45 | In Stock | |
| 10 mg | To Be Confirmed | $73 | In Stock | |
| 100 mg | 98% | $77 | In Stock | |
| 250 mg | 98% | $107 | In Stock | |
| 1 g | 98% | $207 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Bosutinib hydrate is the monohydrate form of anhydrous bosutinib. It functions as an antineoplastic agent and tyrosine kinase inhibitor, containing bosutinib.
| CAS No. | 918639-08-4 |
|---|---|
| Product Name | Bosutinib Monohydrate |
Biological Targets
ABL1·BCR
Associated Conditions
acute myeloid leukemia·myeloid leukemia·chronic myelogenous leukemia
* The information provided here is compiled from public sources and is for reference only.
